--- title: "15:13 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)" type: "News" locale: "en" url: "https://longbridge.com/en/news/294728272.md" description: "Monteverde & Associates PC, a class action law firm, has announced an investigation into Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) regarding its proposed sale to Indivior Pharmaceuticals, Inc. The transaction involves shareholders receiving 1.5401 common shares of Indivior for each Supernus share. The firm is assessing whether the deal is fair and invites shareholders with concerns to contact them for more information." datetime: "2026-08-03T19:13:24.000Z" locales: - [zh-CN](https://longbridge.com/zh-CN/news/294728272.md) - [en](https://longbridge.com/en/news/294728272.md) - [zh-HK](https://longbridge.com/zh-HK/news/294728272.md) generator: "portal-rs" --- # 15:13 ET$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN) , /PRNewswire/ -- **Class Action Attorney** Juan Monteverde **with** Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders and is recognized as a **Top 50 Firm** in the 2025 ISS Securities Class Action Services Report. The firm is headquartered at the **Empire State Building** in New York City and is investigating **Supernus Pharmaceuticals, Inc. (NASDAQ: SUPN)** related to its sale to Indivior Pharmaceuticals, Inc. Under the terms of the proposed transaction, Supernus shareholders are expected to receive 1.5401 common shares of Indivior for each share of Supernus. **Is it a fair deal?** **Click here for more info https://monteverdelaw.com/case/supernus-pharmaceuticals-inc. It is free and there is no cost or obligation to you.** **NOT ALL LAW FIRMS ARE EQUAL.** Before you hire a law firm, you should talk to a lawyer and ask: 1. Do you file class actions and go to Court? 2. When was the last time you recovered money for shareholders? 3. What cases did you recover money in and how much? **About Monteverde & Associates PC** Our firm litigates and has recovered money for shareholders…and we do it from our offices in the Empire State Building. We are a national class action securities firm with a successful track record in trial and appellate courts, including the U.S. Supreme Court. **No one is above the law.** If you own common stock in the above listed company and have concerns or wish to obtain additional information free of charge, please visit our **website** or contact Juan Monteverde, Esq. either via e-mail at **\[email protected\]** or by telephone at (212) 971-1341. Contact: Juan Monteverde, Esq. MONTEVERDE & ASSOCIATES PC **The Empire State Building** 350 Fifth Ave. Suite 4740 New York, NY 10118 United States of America \[email protected\] Tel: (212) 971-1341 Attorney Advertising. (C) 2026 Monteverde & Associates PC. The law firm responsible for this advertisement is Monteverde & Associates PC (www.monteverdelaw.com). Prior results do not guarantee a similar outcome with respect to any future matter. SOURCE Monteverde & Associates PC ### Related Stocks - [SUPN.US](https://longbridge.com/en/quote/SUPN.US.md) - [INDV.US](https://longbridge.com/en/quote/INDV.US.md) - [INDV.UK](https://longbridge.com/en/quote/INDV.UK.md) ## Related News & Research - [Supernus, Indivior agree all-stock merger, combined firm to trade as Supernus on Nasdaq](https://longbridge.com/en/news/294678697.md) - [Supernus and Indivior merge to create scaled, CNS-focused entity](https://longbridge.com/en/news/294826245.md) - [McKenzie Scott PC Announces Three San Diego Civil Rights Case Outcomes](https://longbridge.com/en/news/296538482.md) - [12:10 ETBerger Montague PC Investigates ADMA Biologics, Inc.'s Board of Directors for Breach of Fiduciary Duty (NASDAQ: ADMA)](https://longbridge.com/en/news/296129253.md) - [Honey Badger Silver Announces Participation in the Canada Investment Summit and Provides Corporate Update | HBEIF Stock News](https://longbridge.com/en/news/296384501.md) --- > **Disclaimer: This article is for reference only and does not constitute any investment advice.**